Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

New Hampshire's Medicaid Program Almost Out Of Money
"Rising unemployment and spiking Medicaid and welfare caseloads have put [New Hampshire"s] most recent budget to the test just two weeks after its adoption," New Hampshire Public Radio reports. The state"s Medicaid caseload is just 39 enrollees away from putting the "state"s Medicaid budget in the red."
generic viagra online
Changing Perceptions About Student Drinking Reduces Alcohol Misuse
Giving students personalised feedback on their drinking behaviour and how it compares to social norms might help to reduce alcohol misuse, according to a Cochrane Systematic Review. Drugshop to buy zoloft online and other pills.
News of the day
Collaborative Drug Discovery Partnership To Advance Cancer Drug Development
SRI International, an independent nonprofit research and development organization, has announced that SRI"s Center for Cancer Research was selected by the National Cancer Institute (NCI) for a leading role in the newly-formed "Chemical Biology Consortium" (CBC), a collaborative drug discovery partnership focused on advancing new cancer therapeutics active against novel molecular and genetic cancer targets. Based on its track record of cancer drug discovery and development, SRI was chosen to lead three of the CBC"s research and development centers: Comprehensive Chemical Biology Screening, Chemical Diversity, and Specialized Applications.
Health Insurance

Covidien Announces Health Canada Approval For Its Generic Myocardial Perfusion Imaging Kit

Covidien (NYSE: COV), a leading global provider of healthcare products, announced that Health Canada has approved the Company"s Abbreviated New Drug Submission (ANDS) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien"s generic product is fully substitutable for Cardiolite®, a myocardial perfusion imaging agent used for detecting coronary artery disease. With Health Canada approval of the ANDS, which was filed by the Company"s Canadian subsidiary, Covidien"s generic product is expected to be available for customers in Canada this summer. The Company"s generic product also is available in the U.S., the U.K., Denmark, Germany and Puerto Rico. "We are pleased to receive approval in Canada and to introduce this generic diagnostic option to meet patients" needs," said Timothy R. Wright, President, Pharmaceutical Products and Imaging Solutions, Covidien. Covidien"s Imaging Solutions business is a leading provider of radiopharmaceuticals used in nuclear medicine imaging procedures. It also supplies contrast media delivery systems, which combine contrast media and power injectors, for Computed Tomography (CT), X-ray and Magnetic Resonance Imaging (MRI) procedures. Covidien


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009